Often diagnosed in the teenage years, childhood-onset lupus is a serious, potentially fatal autoimmune disease that causes ...

New research from Swansea University has identified significant delays and diagnostic barriers affecting rheumatology patients in Wales.

Often diagnosed in the teenage years, childhood-onset lupus is a serious, potentially fatal autoimmune disease that causes the body to attack itself. For as many as 10,000 U.S. youths, mostly females ...

Objective The multinational ERYTHRO ( NCT06046534) study investigated the experience of patients with moderate-to-severe SLE ...

Rachel McGlynn wanted the choice to have kids to be hers — not dictated by the treatment for her condition. A decade into her ...

"I'm an odd man out," says Rob Reinhart, who speaks out about his condition to encourage other men to be aware of potential ...

"I always knew something was wrong with me," says Nyobie Gordon-Ricks, a mom of two, who went through years of misdiagnosis ...

The systemic lupus erythematosus (SLE) market continues to evolve toward biologic-driven care, with increasing treatment complexity, intensifying competition among advanced therapies, and a robust ...

Health issues in Black communities are shaped by social, environmental, and genetic factors. Understanding and managing these ...

Roswell Park researchers explore using CAR T-cell therapy to fight autoimmune diseases. Could this revolutionize treatment ...

Please provide your email address to receive an email when new articles are posted on . Obinutuzumab bested placebo in SRI-4 response in adults with systemic lupus erythematosus. The results provide a ...

Biogen’s lupus drug candidate litifilimab has improved outcomes in another phase 2 trial, adding to the momentum behind a program barreling toward pivotal data in two forms of t ...